Moderna jumps 40% after trial results; Merck, BioNTech rise
Moderna is squeezing, now up 40%, while Merck rises 3.4% and BioNTech 3.9% after trial results, with no further catalyst supplied.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.